Stay updated with breaking news from Cardlytics Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fund 1 Investments LLC bought a new position in Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 25,000 shares of the company’s stock, valued at approximately $144,000. Fund 1 Investments LLC owned approximately 0.08% of Cardlytics […]
Antipodean Advisors LLC lessened its stake in Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) by 86.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 75,000 shares of the company’s stock after selling 465,400 shares during the quarter. Cardlytics accounts for about 1.4% of Antipodean […]
Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) saw a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 5,140,000 shares, a decline of 9.5% from the April 15th total of 5,680,000 shares. Based on an average daily trading volume, of 2,360,000 shares, the short-interest ratio is […]
Cardlytics (NASDAQ:CDLX – Get Rating) is scheduled to announce its earnings results after the market closes on Thursday, May 4th. Analysts expect the company to announce earnings of ($0.49) per share for the quarter. Cardlytics has set its Q1 2023 guidance at EPS.Investors that are interested in registering for the company’s conference call can do […]
Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 5,680,000 shares, an increase of 19.3% from the March 31st total of 4,760,000 shares. Based on an average daily volume of 2,230,000 shares, the days-to-cover ratio is presently […]